Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05624905

Prospective Pecutaneous Coronary Intervention Registry

Conditions: Coronary Artery Disease, Percutaneous Coronary Intervention

Sex: All
Ages: 19 Years – N/A
Enrollment: 15000
Sponsor: Samsung Medical Center

Location: Korea, Republic of

Summary

Coronary artery disease is the most important cause of death worldwide. Treatment option for coronary artery disease is medical treatment, percutaneous coronary intervention, or coronary artery bypass surgery. Among them, the field of percutaneous coronary intervention is rapidly developing with regard to the improvement of devices, techniques, or medical treatment, leading to reduce mortality or morbidity. Until now, numerous previous studies related to the risk factors of coronary artery disease and the prognosis of patients have been conducted. However, the field of percutaneous coronary intervention is rapidly evolving, and treatment strategies are constantly being updated. Therefore, the current study sought to identify the long-term prognosis and related risk factors of patients with coronary artery disease who underwent percutaneous coronary intervention.

Eligibility Criteria

Inclusion Criteria:patients who have undergone or are scheduled to undergo coronary angiography and percutaneous coronary intervention.Exclusion Criteria:patients who did not consent to the research

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05624905). StuddyBuddy aggregates publicly available trial information.